Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB13292ApprovedSmall molecule
Pimethixene is approved for use in Brazil and is marketed under the trade name Muricalm. It is an anticholinergic used in the treatment of bronchitis.
- Mechanism
- Curator reviewed
Pharmacologically active on 5-hydroxytryptamine receptor 2B
- Formula / weight
- C19H19NS · 293.43 g/mol (avg)
- Code names
- BP 400
Resolves to
Clinical / RWD
Structure
InChIKey
NZLVRVYNQYGMAB-UHFFFAOYSA-NSMILESCN1CCC(CC1)=C1C2=CC=CC=C2SC2=CC=CC=C12Targets
What you can answer from here — as of July 07, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
Which drugs share a target with Pimethixene, and which of those have an active Phase 3 trial?